Ticker: VKTX

Company: Viking Therapeutics, Inc.

Person: GREG ZANTE, officer

Transaction date: July 28, 2026

Reporting date: July 29, 2026

Average share price: -67.95612218181817

Sold 10450.0 shares for 710141.48